Cerebral metabolism and risperidone treatment in schizophrenia (Q44264699)

1 December 2017

title

Cerebral metabolism and risperidone treatment in schizophrenia (English)

1 reference

1 December 2017

0 references

1 reference

2

1 reference

1 December 2017

6

1 reference

1 December 2017

8

1 reference

1 December 2017

V Molina

1

0 references

author name string

S Reig

3

1 reference

1 December 2017

J Sanz

4

1 reference

1 December 2017

J Pascau

5

1 reference

1 December 2017

T Palomo

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

1 December 2017

published in

Schizophrenia Research

1 reference

1 December 2017

volume

60

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

1-7

1 reference

PET and the [15O]H2O technique, Part 2: Choosing a significance threshold

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

PET and MRI of the thalamus in never-medicated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Positron emission tomography in schizophrenic patients with and without neuroleptic medication

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Thalamic connections of the insula in the rhesus monkey and comments on the paralimbic connectivity of the medial pulvinar nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Combining spatial extent and peak intensity to test for activations in functional imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900199-8

7 January 2021

10.1016/S0920-9964(02)00199-8

Identifiers

DOI

1 reference

1 December 2017

1 reference